[Non-alcoholic fatty liver disease. How and who to screen]

Gastroenterol Hepatol. 2011 Apr;34(4):278-88. doi: 10.1016/j.gastrohep.2010.11.010. Epub 2011 Mar 22.
[Article in Spanish]

Abstract

Non-alcoholic fatty acid disease (NAFLD) can develop in the context of multiple processes but the main etiologic association is undoubtedly with insulin resistance syndrome. The present review aims to provide a systematic diagnostic approach that should include the following basic elements: a) a suspected diagnosis of NAFLD, including confirmation of abstinence from alcohol, exclusion of other potential causes of liver steatosis and diagnosis of potential associated diseases; b) diagnosis of insulin resistance; c) diagnosis of potential associated diseases; d) adequate evaluation of vascular risk; e) diagnosis of the type and localization of fat, and finally, f) evaluation of the severity of NAFLD, which can be performed through invasive and non-invasive techniques.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Atherosclerosis / epidemiology
  • Biomarkers
  • Body Fat Distribution
  • Comorbidity
  • Elasticity Imaging Techniques
  • Fatty Liver* / chemically induced
  • Fatty Liver* / diagnosis
  • Fatty Liver* / diagnostic imaging
  • Fatty Liver* / epidemiology
  • Fatty Liver* / etiology
  • Humans
  • Insulin Resistance
  • Lipids / blood
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / pathology
  • Liver Function Tests
  • Mass Screening* / methods
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / epidemiology
  • Non-alcoholic Fatty Liver Disease
  • Patient Selection
  • Predictive Value of Tests
  • Risk Factors
  • Severity of Illness Index

Substances

  • Biomarkers
  • Lipids